Porton Fine (China) Today

300363 Stock   17.46  0.50  2.78%   

Performance

Weak

 
Weak
 
Strong

Odds Of Distress

Quite High

 
High
 
Low
Porton Fine is trading at 17.46 as of the 26th of February 2025, a 2.78 percent decrease since the beginning of the trading day. The stock's open price was 17.96. Porton Fine has more than 68 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 28th of November 2024 and ending today, the 26th of February 2025. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
Category
Healthcare
Classification
Health Care
Porton Fine is entity of China. It is traded as Stock on SHE exchange. The company has 545.47 M outstanding shares. More on Porton Fine Chemicals

Moving together with Porton Stock

  0.85001289 China Longyuan PowerPairCorr
  0.61300600 Changshu Ruite ElectricPairCorr

Moving against Porton Stock

  0.63601857 PetroChinaPairCorr
  0.56601988 Bank of China LimitedPairCorr

Porton Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Porton Fine's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Porton Fine or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Chairman GMNianfeng Ju
Thematic Ideas
(View all Themes)
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Chemicals Makers, Synthetics, Health Care, Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors)
Porton Fine's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Porton Fine's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
Porton Fine can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Porton Fine's financial leverage. It provides some insight into what part of Porton Fine's total assets is financed by creditors.
Liquidity
Porton Fine cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Porton Fine Chemicals has accumulated 20.03 M in total debt. Debt can assist Porton Fine until it has trouble settling it off, either with new capital or with free cash flow. So, Porton Fine's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Porton Fine Chemicals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Porton to invest in growth at high rates of return. When we think about Porton Fine's use of debt, we should always consider it together with cash and equity.

Other Cashflows From Financing Activities

477.72 Million
Porton Fine Chemicals (300363) is traded on Shenzhen Stock Exchange in China and employs 4,915 people. Porton Fine is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 9.61 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Porton Fine's market, we take the total number of its shares issued and multiply it by Porton Fine's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Porton Fine Chemicals operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 545.47 M outstanding shares. Porton Fine generates positive cash flow from operations, but has no cash available
Check Porton Fine Probability Of Bankruptcy
Ownership Allocation
Porton Fine owns a total of 545.47 Million outstanding shares. Porton Fine has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Porton Ownership Details

Porton Fine Chemicals Risk Profiles

Although Porton Fine's alpha and beta are two of the key measurements used to evaluate Porton Fine's performance over the market, the standard measures of volatility play an important role as well.

Porton Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Porton Fine without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Optimization Now

   

Portfolio Optimization

Compute new portfolio that will generate highest expected return given your specified tolerance for risk
All  Next Launch Module

Porton Fine Corporate Management

Elected by the shareholders, the Porton Fine's board of directors comprises two types of representatives: Porton Fine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Porton. The board's role is to monitor Porton Fine's management team and ensure that shareholders' interests are well served. Porton Fine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Porton Fine's outside directors are responsible for providing unbiased perspectives on the board's policies.
Yaohui JiDeputy MangProfile
Xiongbin MaDeputy ManagerProfile
Qing YuDeputy MangProfile
Yongmei YuDeputy MangProfile
Jianguo MaChief OfficerProfile

Other Information on Investing in Porton Stock

Porton Fine financial ratios help investors to determine whether Porton Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Porton with respect to the benefits of owning Porton Fine security.